Crestor and Ebrantil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Crestor (rosuvastatin calcium) and Ebrantil (urapidil). Common drug interactions include arthritis among females and bone pain among males.

The phase IV clinical study analyzes what interactions people have when they take Crestor and Ebrantil. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,762 Crestor users. Check the latest studies of Crestor.

What is Ebrantil?

Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

26 people who take Crestor and Ebrantil together, and have interactions are studied.

What are the common drug interactions of Crestor and Ebrantil, by gender? *:

female:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
Constipation
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Diarrhoea
Hypertension (high blood pressure)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Rash
Visual field defect

male:

Bone pain
Food poisoning (poison in food)
Abdominal discomfort
Body height decreased
Lung neoplasm malignant (cancer tumour of lung)
Pain
Pulmonary embolism (blockage of the main artery of the lung)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Rash
Haemorrhagic infarction (stroke caused by the rupture of a blood vessel in the brain)

What are the common drug interactions of Crestor and Ebrantil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
Constipation
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Diarrhoea
Hypertension (high blood pressure)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Rash
Visual field defect

40-49:

n/a

50-59:

Haemorrhagic infarction (stroke caused by the rupture of a blood vessel in the brain)
Hypertension (high blood pressure)
Carotid artery dissection
Cerebral infarction (less blood supply to brain resulting tissue damage)
Drug ineffective
Nausea (feeling of having an urge to vomit)

60+:

Bone pain
Food poisoning (poison in food)
Abdominal discomfort
Body height decreased
Lung neoplasm malignant (cancer tumour of lung)
Pain
Pulmonary embolism (blockage of the main artery of the lung)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Rash
Hypernatraemia (an abnormally high plasma concentration of sodium ions)

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 34.62%
Diarrhea: 5 people, 19.23%
Visual Field Defect: 4 people, 15.38%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 4 people, 15.38%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 4 people, 15.38%
Constipation: 4 people, 15.38%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 15.38%
Iron Deficiency Anaemia: 4 people, 15.38%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 15.38%
Gastritis (inflammation of stomach): 4 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and Ebrantil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously